Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.81 USD
+0.08 (2.93%)
Updated Oct 11, 2024 11:30 AM ET
2-Buy of 5 2
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
RKDA 2.81 +0.08(2.93%)
Will RKDA be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for RKDA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RKDA
Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates
RKDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hydrofarm Holdings Group, Inc. (HYFM) Reports Q2 Loss, Tops Revenue Estimates
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
Other News for RKDA
Warning: RKDA is at high risk of performing badly
Lake Street Sticks to Its Buy Rating for Arcadia Biosciences (RKDA)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Arcadia Biosciences Inc (RKDA) Q2 2024 Earnings Call Transcript Highlights: Strong Zola Sales ...
Arcadia Biosciences: Q2 Earnings Snapshot